A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/12/2006	US7148036 DNA molecules encoding cartilage-derived morphogenetic proteins
12/12/2006	US7148022 Assay for anti-viral agent
12/12/2006	US7148021 Human zona pellucida proteins and methods of their use in diagnosing male infertility
12/12/2006	US7148020 Triple polypeptide complexes
12/12/2006	US7148019 Treating grass pollen allergen by administering a genetic engineered or synthetic protein or polypeptide; antiallergens
12/12/2006	US7148014 Methods of inhibiting phagocytosis
12/12/2006	US7148013 Complex of Hepatitis B virus polymerase with p11 and method for controlling movement of the complex in HepG2 cell
12/12/2006	US7148011 Method of testing for allergic diseases
12/12/2006	US7148003 Bioassay to determine inhibition of the peptidyl-prolyl isomerase activity of a Pin1 protein; antimitotic agents
12/12/2006	US7148002 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
12/12/2006	US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006	US7147862 Vaccines containing QS21, an Hplc purified non-toxic fraction derived from the bark of Quillaja Saponaria Molina, and 3 De-O-acylated monophosphoryl lipid A (3 D-MPL); combinations of QS21 and 3 D-MPL synergistically enhance immune responses to a given antigen
12/12/2006	US7147857 Methods for treating high somatic cell counts
12/12/2006	US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
12/12/2006	US7147854 Administering a monoclonal antibody which is a murine anti-human IL-8 monoclonal antibody, for treating skin inflammatory diseases
12/12/2006	US7147853 Nucleotide sequences codin polypeptide for use in the treatment and prevention of cell proliferative and tumor disorders
12/12/2006	US7147852 Methods for reducing TGF-β production and for promoting repair of liver damage
12/12/2006	US7147851 Humanized immunoglobulin reactive with α4β7 integrin
12/12/2006	US7147849 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity
12/12/2006	US7147847 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases
12/12/2006	US7147839 Methods for evaluating tissue morphogenesis and activity
12/12/2006	US7147838 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases
12/12/2006	CA2201598C Vaccine compositions
12/12/2006	CA2189659C Production of biologically active recombinant neurotrophic protein
12/12/2006	CA2179294C Low molecular weight hyaluronic acid with peptide or protein
12/12/2006	CA2167080C Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins
12/12/2006	CA2153336C Recombinant virus immunotherapy
12/12/2006	CA2140106C Method of treating hyperproliferative vascular disease
12/12/2006	CA2129045C Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
12/12/2006	CA2098176C Angiotensin ii receptor blocking compositions
12/07/2006	WO2006130718A2 Synthetic peptide inhibitors of thrombin
12/07/2006	WO2006130676A2 Inhibition of neuronal damage
12/07/2006	WO2006130471A1 The use delta opioid receptor agonists and/or inverse agonists to inhibit the consumption of substances of abuse
12/07/2006	WO2006130171A1 Cell nucleus-entering compositions
12/07/2006	WO2006130161A2 Therapeutic compounds derived from spider venom and their method of use
12/07/2006	WO2006130090A1 Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders
12/07/2006	WO2006130082A1 A peptide ligand to impair cancer cell migration
12/07/2006	WO2006130076A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis
12/07/2006	WO2006130034A1 Method for increasing longevity of a human being and animals
12/07/2006	WO2006130022A1 Modulation of ovulation by agonists and antagonists of bmprii
12/07/2006	WO2006129995A1 Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent
12/07/2006	WO2006129881A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent
12/07/2006	WO2006129867A2 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN
12/07/2006	WO2006129849A1 Anti-cd14 antibody-fused protein
12/07/2006	WO2006129785A1 Concomitant pharmaceutical agents and use thereof
12/07/2006	WO2006129755A1 Therapeutic agent for blood-related disease containing epo derivative
12/07/2006	WO2006129393A1 Composition for treating periodontal disease
12/07/2006	WO2006129317A1 BACKBONE CYCLIZED MELANOCORTIN STIMULATING HORMONE (α S ) ANALOGS
12/07/2006	WO2006129105A1 Fk 228 derivates as hdac inhibitors
12/07/2006	WO2006129095A2 Sustained release preparations of pro-insulin c-peptide
12/07/2006	WO2006128951A1 Compositions for targeting amine oxidases in vivo
12/07/2006	WO2006128679A2 Phosphatidylinositol composition and 3'-phosphorylated lysophosphatidylinositols in the treatment of cancer and autoimmune diseases
12/07/2006	WO2006128497A1 Pharmaceutical formulation of factor xi
12/07/2006	WO2006128471A2 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
12/07/2006	WO2006128293A1 Kinin b1 receptor peptide agonists and uses thereof
12/07/2006	WO2006128289A1 Use of brevinin-2r in the treatment of cancer
12/07/2006	WO2006128266A2 Pharmaceutical compositions of the peptide angiotensin-(1 -7) [ang-(i -7)] and its analogues, agonists and antagonists, for use in controlling the functions of the reproductive system
12/07/2006	WO2006111524A3 Il-21 variants
12/07/2006	WO2006109303A3 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
12/07/2006	WO2006109301A3 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
12/07/2006	WO2006105359A3 Methods for stimulating hair growth by administering bmps
12/07/2006	WO2006105317A3 Antitumorigemic drug combination comprising a vegf-inhibitor and a thrombospondin-1 peptidomimetic
12/07/2006	WO2006103494A3 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
12/07/2006	WO2006099309A3 Keratin and soluble derivatives thereof for treating oxidative stress and inflammation and promoting skin health
12/07/2006	WO2006096515A3 Modified transferrin fusion proteins
12/07/2006	WO2006095234A3 Integrin targeted synthetic ligands for diagnostic and therapeutic applications
12/07/2006	WO2006092326A3 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
12/07/2006	WO2006089056A3 Apparatus and method for transdermal delivery of erythropoetin-based agents
12/07/2006	WO2006086822A9 A molecule and chimeric molecules thereof
12/07/2006	WO2006083390A3 Eotaxin-3 in eosinophilic esophagitis
12/07/2006	WO2006081418A3 Ephb receptor-binding peptides
12/07/2006	WO2006078840A3 Modulation of serotonin transporters
12/07/2006	WO2006053565A3 Polypeptides having antimicrobial activity and polynucleotides encoding same
12/07/2006	WO2006052608A3 Treatment of obesity and related disorders
12/07/2006	WO2006037811A3 Protracted exendin-4 compounds
12/07/2006	WO2006028496A3 Lesion repair polymerase compositions
12/07/2006	WO2006026604A3 Methods for promoting wound healing
12/07/2006	WO2006020580A3 Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
12/07/2006	WO2006015137A3 A method for managing cholesterol with a serum-free and mitogen free cytokine mixture
12/07/2006	WO2006014559A3 Cyclic peptides for treatment of cachexia
12/07/2006	WO2006007509A3 Epidermal growth factor receptor antagonists and methods of use
12/07/2006	WO2006006165A3 Use of erythropoietin for enhancing immune responses and for treatment of lymphoproliferative disorders
12/07/2006	WO2005115405A8 Methods for treating or preventing restenosis and other vascular proliferative disorders
12/07/2006	WO2005110464A3 Irx5 inhibition as treatment for hyperproliferative disorders
12/07/2006	WO2005108563A3 Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4
12/07/2006	WO2005105135A8 Il-6 for therapy or prevention of chemotherapy-induced neuropathy
12/07/2006	WO2005079848A9 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
12/07/2006	WO2005044992A3 Fusion initiation region in rna virus envelope proteins
12/07/2006	WO2005018491A3 Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and a method for use thereof
12/07/2006	WO2004100861A3 Pharmaceutical composition comprising lectin
12/07/2006	WO2004074454A3 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
12/07/2006	WO2003029401A8 Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
12/07/2006	WO2002036732A3 Active variants of fgf with improved specificity
12/07/2006	US20060277614 Mammal prolactin variants
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276635 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/07/2006	US20060276634 PEG-conjugated erythropoietin
12/07/2006	US20060276627 Angiotensin-converting enzyme inhibitory peptides
12/07/2006	US20060276626 Methods for the production of peptide derivatives
12/07/2006	US20060276623 Scaffolds; resistant enterococci

1 ... 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 ... 3163